| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
468,681,000 |
| Market
Cap: |
2.92(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$4.46 - $21.07 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : 11.5 |
| Insider 3/6 Months : 14.1 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Agilon Health is a holding company. Through its subsidiaries, Co.'s business is transforming healthcare by enabling the primary care physicians to be the agents for change in the communities they serve. Co.'s purpose-built model provides the capabilities, capital and business model for existing physician groups to create a Medicare-centric, globally capitated line of business. Co.'s model operates by primarily forming risk-bearing entities within local geographies, that enter into arrangements with payors providing for monthly payments to manage the total healthcare needs of its physician partners' attributed patients (or global capitation arrangements).
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
312,224 |
334,524 |
379,214 |
382,114 |
| Total Buy Value |
$0 |
$250,206 |
$747,945 |
$797,650 |
| Total People Bought |
5 |
6 |
7 |
7 |
| Total Buy Transactions |
5 |
6 |
7 |
8 |
| Total Shares Sold |
0 |
0 |
176,250 |
107,451,522 |
| Total Sell Value |
$0 |
$0 |
$3,189,799 |
$2,147,483,647 |
| Total People Sold |
0 |
0 |
2 |
6 |
| Total Sell Transactions |
0 |
0 |
9 |
83 |
| End Date |
2024-02-29 |
2023-11-28 |
2023-05-30 |
2022-05-30 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Mansukani Sharad |
Director |
– • – |
2021-09-14 |
4 |
S |
$28.98 |
$4,528,125 |
D/D |
(156,250) |
1,229,356 |
|
46% |
|
| Mansukani Sharad |
Director |
– • – |
2021-09-14 |
4 |
OE |
$1.00 |
$156,250 |
D/D |
156,250 |
1,385,606 |
|
- |
|
| Kornitzer Benjamin |
Chief Med. & Quality Officer |
• – – |
2021-09-14 |
4 |
S |
$28.98 |
$332,546 |
D/D |
(11,475) |
5,434 |
|
46% |
|
| Kornitzer Benjamin |
Chief Med. & Quality Officer |
• – – |
2021-09-14 |
4 |
OE |
$4.50 |
$51,638 |
D/D |
11,475 |
16,909 |
|
- |
|
| Dombro Lisa |
Exper. & Innovation Officer |
• – – |
2021-09-14 |
4 |
S |
$28.98 |
$1,783,516 |
D/D |
(61,543) |
11,956 |
|
46% |
|
| Dombro Lisa |
Exper. & Innovation Officer |
• – – |
2021-09-14 |
4 |
OE |
$1.00 |
$61,543 |
D/D |
61,543 |
73,499 |
|
- |
|
| Cd&r Vector Holdings, L.p. |
10% Owner |
– – • |
2021-09-14 |
4 |
S |
$28.98 |
$518,865,368 |
I/I |
(17,904,257) |
205,948,808 |
|
46% |
|
| Schnall Richard J |
Director |
– • – |
2021-09-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
119,989 |
0 |
|
- |
|
| Schnall Richard J |
Director |
– • – |
2021-09-09 |
4 |
A |
$0.00 |
$0 |
D/D |
119,989 |
119,989 |
|
- |
|
| Cd&r Vector Holdings, L.p. |
10% Owner |
– – • |
2021-09-09 |
4 |
D |
$0.00 |
$0 |
I/I |
(865,112) |
223,853,065 |
|
- |
|
| Mcloughlin Karen |
Director |
– • – |
2021-07-14 |
4 |
A |
$0.00 |
$0 |
D/D |
3,489 |
3,489 |
|
- |
|
| Gourdine Michelle A |
Director |
– • – |
2021-04-19 |
4 |
B |
$23.00 |
$115,000 |
D/D |
5,000 |
11,956 |
2.39 |
10% |
|
| Richards Clay |
Director |
– • – |
2021-04-19 |
4 |
B |
$23.00 |
$499,100 |
D/D |
21,700 |
28,656 |
2.39 |
10% |
|
| Smith Michael L |
Director |
– • – |
2021-04-14 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
150,000 |
|
- |
|
| Smith Michael L |
Director |
– • – |
2021-04-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
145,100 |
|
- |
|
| Kornitzer Benjamin |
Chief Med. & Quality Officer |
• – – |
2021-04-14 |
4 |
A |
$0.00 |
$0 |
D/D |
5,434 |
5,434 |
|
- |
|
| Gourdine Michelle A |
Director |
– • – |
2021-04-14 |
4 |
A |
$0.00 |
$0 |
D/D |
6,956 |
6,956 |
|
- |
|
| Dombro Lisa |
Exper. & Innovation Officer |
• – – |
2021-04-14 |
4 |
A |
$0.00 |
$0 |
D/D |
11,956 |
11,956 |
|
- |
|
| Mansukani Sharad |
Director |
– • – |
2021-04-14 |
4 |
A |
$0.00 |
$0 |
D/D |
6,956 |
1,229,356 |
|
- |
|
| Halkias Theodore |
Chief Business Officer |
• – – |
2021-04-14 |
4 |
A |
$0.00 |
$0 |
D/D |
5,434 |
5,434 |
|
- |
|
| Bensley Timothy |
Chief Financial Officer |
• – – |
2021-04-14 |
4 |
A |
$0.00 |
$0 |
D/D |
14,945 |
14,945 |
|
- |
|
| Shaker Benjamin |
Chief Markets Officer |
• – – |
2021-04-14 |
4 |
A |
$0.00 |
$0 |
D/D |
13,586 |
113,586 |
|
- |
|
| Sobotka Glenn |
Chief Accounting Officer |
• – – |
2021-04-14 |
4 |
A |
$0.00 |
$0 |
D/D |
3,260 |
3,260 |
|
- |
|
| Williams Ronald A |
Director |
– • – |
2021-04-14 |
4 |
A |
$0.00 |
$0 |
D/D |
6,956 |
2,451,856 |
|
- |
|
| Venkatachaliah Girish |
Chief Technology Officer |
• – – |
2021-04-14 |
4 |
A |
$0.00 |
$0 |
D/D |
5,434 |
5,434 |
|
- |
|
337 Records found
|
|
Page 13 of 14 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.48 (8.33%) 
